15 results
8-K
EX-10.1
BCLI
Brainstorm Cell Therapeutics, Inc.
19 Jul 23
Brainstorm Cell Therapeutics Announces Pricing of $7.5 Million Registered Direct Offering
4:05pm
of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any
8-K
EX-99.2
BCLI
Brainstorm Cell Therapeutics, Inc.
28 Jan 22
BrainStorm Cell Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
4:10pm
, BrainStorm Cell Therapeutics, Inc.
Yeah. Thank you for the question, Michael. I’ll start with our MS program. As you recall in Chaim’s prepared comments
8-K
EX-10.1
BCLI
Brainstorm Cell Therapeutics, Inc.
13 Jun 14
Entry into a Material Definitive Agreement
12:00am
, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales
424B3
y43ek 9vzvvip46d0
16 Aug 13
Prospectus supplement
12:00am
424B1
tvodx1knyzo2g5vhzgad
19 Jul 12
Prospectus with pricing info
12:00am
10-K
05m7eeshz3muo28 1l
15 Apr 09
Annual report
12:00am
- Prev
- 1
- Next